Diabetes Clinical Trials in San Diego, CA

65 recruiting studies within 50 miles

Phase

Trial	Phase	Sponsor	Dist.
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)	Phase 2	Sparrow Pharmaceuticals	<1 mi
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma	Phase 2	Children's Oncology Group	<1 mi
Enhancing Digitally Delivered Diabetes Education With Real-Time CGM	N/A	Scripps Whittier Diabetes Institute	<1 mi
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease	Phase 3	Boehringer Ingelheim	<1 mi
Automated Insulin for Management of Intrapartum Glycemia	N/A	University of California, San Francisco	<1 mi
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)	Phase 1/2	COUR Pharmaceutical Development Company, Inc.	<1 mi
A Prospective Clinical Study to Evaluate the Effectiveness and Safety of Xcell Amnio MatrixTM (XAM) in the Management of Chronic Non-healing DFUs	N/A	New Horizon Medical Solutions	<1 mi
More Fresh Fruit and Vegetable Prescription Program for Families With Type 2 Diabetes Mellitus	N/A	University of California, San Diego	<1 mi
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes	Phase 4	VA Office of Research and Development	<1 mi
Dulce Digital 2.0 - Innovative Diabetes Self-Management in the Digital Age	N/A	Scripps Whittier Diabetes Institute	<1 mi
Efficacy of Using Mobile Health Applications for Health	N/A	San Diego State University	<1 mi
Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease	Phase 2	Pharming Technologies B.V.	<1 mi
A Study of GNTI-122 in Adults Recently Diagnosed With T1D	Phase 1	GentiBio, Inc	<1 mi
Implementing Food Referrals for Equity and Sustained Health	Phase 2	University of California, San Diego	<1 mi
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin	Phase 3	Eli Lilly and Company	<1 mi
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)	Phase 2/3	CSL Behring	<1 mi
ACT1VATE: Addressing Emotional Distress to Improve Outcomes Among Diverse Adults With Type 1 Diabetes	Phase 2	Scripps Whittier Diabetes Institute	<1 mi
North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)	—	Columbia University	<1 mi
Efficacy of mHealth Apps for Health in a Low-income, Type II Diabetic, Hispanic Population	N/A	San Diego State University	<1 mi
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)	—	Jaeb Center for Health Research	<1 mi
Continuous Glucose Monitoring for Self-Management of Type 2 Diabetes in Young Adults	N/A	San Diego State University	<1 mi
CGM for Management of Type 2 Diabetes in Pregnancy	N/A	University of Alabama at Birmingham	<1 mi
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes	Phase 3	Hoffmann-La Roche	<1 mi
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy	Phase 2	Biomea Fusion Inc.	<1 mi
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight	Phase 3	Novo Nordisk A/S	<1 mi
A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes	Phase 2	Novo Nordisk A/S	<1 mi
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus	Phase 3	AstraZeneca	<1 mi
CAMPR-II RWE TRIAL: A Saline-hydrated Allogeneic Dual-layer Amniotic Membrane Product or a Synthetic, Resorbable Polymeric Wound Matrix to a Coarsened Exact Matched Retrospective Control Cohort of Hard to Heal DFUs and VLUs	N/A	Capsicure, LLC	<1 mi
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)	Phase 3	Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics	<1 mi
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications	Phase 3	Novo Nordisk A/S	<1 mi
A Single Bolus, 12-hour Euglycemic Clamp Study of the Safety, Pharmacokinetics (PK) and Glucodynamics (GD) of Intraperitoneal (IP) Portal Insulin U-500	Phase 1	Portal Diabetes, Inc.	7 mi
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events	N/A	Cleerly, Inc.	7 mi
Latinos Understanding the Need for Adherence in Diabetes Using E-Health	N/A	San Diego State University	7 mi
A Study to Evaluate ALN-4324 on Insulin Sensitivity in Adults With Type 2 Diabetes Mellitus	Phase 2	Alnylam Pharmaceuticals	7 mi
A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Orally Administered TIX100 in Healthy Subjects	Phase 1	TIXiMED, Inc.	7 mi
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)	Phase 3	Amgen	7 mi
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes	Phase 3	Ascletis Pharma (China) Co., Limited	7 mi
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes	Phase 3	Kailera	9 mi
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes	Phase 3	Eli Lilly and Company	10 mi
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes	Phase 3	Hoffmann-La Roche	10 mi
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar	Phase 3	Boehringer Ingelheim	10 mi
THC Effects on Glucose in Type 2 Diabetes	Phase 1	University of California, San Diego	11 mi
Closed Loop and Education for Hypoglycemia Awareness Restoration	N/A	Milton S. Hershey Medical Center	11 mi
Long Term Impact of Time-Restricted Eating on Parameters of Cardiometabolic Health	Phase 2	University of California, San Diego	11 mi
Acetazolamide in Persons With Type 1 Diabetes - Crossover Trial	Phase 2	University of California, San Diego	11 mi
Behavioral Approach for Latinas Addressing Nutrition, Cravings, and Eating Patterns to Prevent Type 2 Diabetes	N/A	University of California, San Diego	11 mi
Time Restricted Eating in Patients With Microalbuminuria	Phase 1	University of California, San Diego	11 mi
Project Dulce for Arab Americans With Type 2 Diabetes	N/A	Scripps Whittier Diabetes Institute	13 mi
Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema	Phase 2/3	AbbVie	19 mi
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus	Phase 3	AstraZeneca	24 mi
Accuracy and Precision of the Continuous Glucose Monitoring System 'CareSens Air 3' in Adult Patients With T1DM	N/A	i-SENS, Inc.	28 mi
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes	Phase 2	Zucara Therapeutics Inc.	28 mi
Gemini Study: A Prospective, Multicenter Evaluation of Performance and Safety of the Eversense Gemini System With Flash Glucose Measurement Feature	N/A	Senseonics, Inc.	28 mi
Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes	Phase 3	Kailera	28 mi
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes	Phase 3	Eli Lilly and Company	28 mi
AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight	Phase 3	Novo Nordisk A/S	28 mi
ROME GS System Study	N/A	Senseonics, Inc.	28 mi
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity	Phase 3	Pfizer	28 mi
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus	Phase 3	AstraZeneca	28 mi
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus	Phase 3	AstraZeneca	28 mi
Trial to Evaluate the Safety and Effectiveness of Treatment With COMS One Device in Subjects With Diabetic Foot Ulcers	N/A	Piomic Medical	34 mi
EDX110 Randomized Control Trial for Treatment of DFUs	N/A	ConvaTec Inc.	34 mi
Study Assessing Complete Wound Healing by Comparing Surgenex® PelloGraft in Treating DFU and SanoGraft® in Treating VLU to SOC	N/A	Surgenex	34 mi
Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot Ulcers	N/A	Tides Medical	34 mi
Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes	Phase 3	Kailera	36 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.